IGHE and allergic disease: The first key questions to answer in cases with suspected severe MC activation and thus MCAS are whether the patient is suffering from a severe IgE-dependent allergy, whether the patient is suffering from a true MCAS and whether mediator-targeting drugs alone are sufficient to stabilize the condition [63,64,65].